New Oncology Drugs/Indications Approved by the FDA.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 171
- Publication type:
- Article
Works matching IS 21641153 AND DT 2021 AND VI 11 AND IP 3
Results: 13
1
2
Managing Thromboembolism in Patients with Cancer: Which Are the Preferred Anticoagulants?
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 169
- Publication type:
- Article
3
Cancer Pain Management and the Opioid Conundrum: Optimizing Outcomes, Minimizing Risks.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 168
- Publication type:
- Article
4
Immunotherapy Continues to Transform the Treatment Landscape for Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 167
- Publication type:
- Article
5
New Opportunities for Pharmacists in Clinical Trials and Drug Development After COVID-19.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 166
- Publication type:
- Article
6
Eliminating Structural Racism in Oncology Pharmacy: Individual and Organizational Responsibility.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 165
- Publication type:
- Article
7
The Impact of Racial Disparities in Cancer Care: Racism a Risk Factor for Poor Clinical Outcomes.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 164
- Publication type:
- Article
8
Pegaspargase-Induced Diabetic Ketoacidosis in a Patient with Acute Lymphoblastic Leukemia.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 160
- By:
- Publication type:
- Article
9
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 156
- By:
- Publication type:
- Article
10
How I Treat Anemia Associated with Lower-Risk Myelodysplastic Syndromes.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 150
- By:
- Publication type:
- Article
11
Pharmacy Resident-Led Medication Reconciliation and Patient Education Service in Adults with Leukemia Receiving Anticancer Oral Agents: A Pilot Study.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 143
- By:
- Publication type:
- Article
12
Immune-Related Adverse Events Linked to Immune Checkpoint Inhibitors: Retrospective Analysis of a Single-Center Veteran Population.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 127
- By:
- Publication type:
- Article
13
Denosumab for First-Line Treatment of Hypercalcemia Associated with Malignancy: Retrospective Analysis.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 121
- By:
- Publication type:
- Article